KALA Bio Insider to Sell 5,251 Shares Worth $21,000 on NASDAQ

Form 144 Notice of Proposed Sale filed for Kala Bio (NASDAQ: KALA) indicates an insider's intent to sell 5,251 shares of common stock with an aggregate market value of $21,056.51 through E*TRADE Financial Corporation.

Rhea-AI Filing Summary

Form 144 Notice of Proposed Sale filed for Kala Bio (NASDAQ: KALA) indicates an insider's intent to sell 5,251 shares of common stock with an aggregate market value of $21,056.51 through E*TRADE Financial Corporation. The planned sale is scheduled for June 24, 2025.

The securities being sold were originally acquired through a Restricted Stock Unit (RSU) vesting on June 24, 2025, where the insider received 16,450 shares as equity compensation. The total shares outstanding for Kala Bio are reported at 6,452,398.

Recent trading activity by the same seller through E*TRADE includes a previous sale of 3,687 shares on June 3, 2025, which generated gross proceeds of $13,789.38. This Form 144 filing represents the seller's declaration that they are not aware of any material adverse non-public information regarding the company.

Positive

• None.

Negative

• Insider selling 5,251 shares worth $21,056 following recent sale of 3,687 shares in June, indicating continued selling pressure from insiders

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares of KALA stock are being sold according to the Form 144 filing from June 2025?

According to the Form 144 filing, 5,251 shares of KALA common stock are proposed to be sold through ETRADE FINANCIAL CORPORATION at an aggregate market value of $21,056.51.

What is the total outstanding shares of KALA Bio as of June 2025?

According to the Form 144 filing, KALA Bio has 6,452,398 shares outstanding as of June 2025.

How did the insider acquire the KALA shares being sold?

The shares were acquired through Restricted Stock Unit (RSU) vesting on June 24, 2025, as part of equity compensation from the issuer. The total amount of securities acquired was 16,450 shares.

What previous KALA stock sales were reported by the insider in the past 3 months?

The filing shows that the insider sold 3,687 shares of KALA common stock on June 3, 2025, through ETRADE FINANCIAL CORPORATION for gross proceeds of $13,789.38.

What is the planned date of sale for the KALA shares in this Form 144?

The approximate date of sale is listed as June 24, 2025, and the shares are planned to be sold on the NASDAQ exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/24/2025 - 08:01 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001298079
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	KALA BIO, INC.
SEC File Number	001-38150
Address of Issuer	1167 MASSACHUSETTS AVENUE ARLINGTON MASSACHUSETTS 02476
Phone	781-996-5252
Name of Person for Whose Account the Securities are To Be Sold	Romulus K Brazzell
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETRADE FINANCIAL CORPORATION 3 EDISON DRIVE ALPHARETTA GA 30005	5251	21056.51	6452398	06/24/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/24/2025	Restricted Stock Unit Vesting	Issuer			16450	06/24/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ETRADE FINANCIAL CORPORATION 3 EDISON DRIVE ALPHARETTA GA 30005	Common Stock	06/03/2025	3687	13789.38

144: Remarks and Signature

Remarks	Represents the sale of shares of common stock pursuant to a "sell-to-cover" transaction in order to satisfy tax withholding obligations in connection with the vesting of RSUs previously granted to the Reporting Person. This sale was effected pursuant to an automatic sell-to-cover instruction effected pursuant to Rule 10b5-1 adopted by the Reporting Person on November 9, 2020 and does not represent a discretionary sale by the Reporting Person.
Date of Notice	06/24/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mary Reumuth, Attorney-in-Fact
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)